Earlier this month, researchers reported unpublished preliminary results from a pilot drug study for ADNP syndrome, a rare genetic disorder often accompanied by autism. During the nearly one-year study, 10 children, ages 6 to 12, took a low dose of ketamine. The drug is approved for the treatment of depression and is used in higher […]
